Abbvie Inc (ABBV) Stock Price, Graph, News & Analysis
Manufacturing (Pharmaceutical Preparation Manufacturing ) | NEW YORK STOCK EXCHANGE INC. : ABBV
$153.91 -$0.74 (-0.48%)
Market Status : Closed
Last Update :
9/26/2023 4:00:51 PM
AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. Their primary product is Humira (adalimumab) Read More
Historical Price Graph
Performance
| 1 Month | 3 Month | 6 Month | YTD | 1 Year | 3 Year | 5 Year |
|---|---|---|---|---|---|---|
| 5.43% | 15.04% | -0.14% | -1.43% | 12.49% | 56.45% | 108.43% |
Details
Exchange
NEW YORK STOCK EXCHANGE INC.
Industry
Pharmaceutical Preparation Manufacturing
Website
https://www.abbvie.com/
Sector
Manufacturing
CEO
Richard Gonzalez
Total Employees
50,000
SIC Code
2834
Market Cap
$ 271.66 B
Key Statistics
Dividend Rate
$5.76
Last Dividend
2023-07-13
Dividend Yield
3.73%
P/E Ratio
31.6
Price Range (52 Week)
$128.86 - $164.38
Latest Volume
$ 3.94 M
Average Total Volume
$ 4.10 M
Outstanding Shares
1,765,046,680
Beta
33.19%
Similar Stocks
| Companyarrow_upward | Sectorarrow_upward | Latest Pricearrow_upward | Changearrow_upward |
|---|---|---|---|
| Merck & Co Inc (MRK) | Health Technology | $105.39 | -$0.45 |
| Costco Wholesale Corp (COST) | Retail Trade | $552.96 | -$5.66 |
| Coca-Cola Co (KO) | Consumer Non-Durables | $56.53 | -$0.47 |
| PepsiCo Inc (PEP) | Consumer Non-Durables | $172.52 | -$1.81 |
| Adobe Inc (ADBE) | Technology Services | $506.30 | -$5.30 |
Abbvie Inc in News
Seeking Alpha (ABBV,4AB-GF,4AB-GM,4AB-GY,4AB-GS,4AB-GD,4AB-GB)
AbbVie''s Tepkinly wins EC approval as large B-cell lymphoma therapy The European Commission has approved AbbVie''s Tepkinly (epcoritamab) as a third-line treatment for Sep 25, 2023 10:18 AM
Insider Monkey (ABBV,4AB-GF,4AB-GM,4AB-GY,4AB-GS,4AB-GD,4AB-GB)
5 Best Dividend Kings Stocks to Buy Now In this article, we discuss 5 best dividend king stocks to buy now. If you want to read our detailed Sep 25, 2023 9:45 AM
Investor''s Business Daily (ABBV,4AB-GF,4AB-GM,4AB-GY,4AB-GS,4AB-GD,4AB-GB)
AbbVie Stock Shows Rising Relative Strength Rating AbbVie shows improving price performance, earning an upgrade to its IBD Relative Strength Rating Sep 21, 2023 4:06 PM
Independent Ireland (ABBV,4AB-GF,4AB-GM,4AB-GY,4AB-GS,4AB-GD,4AB-GB)
US pharma group AbbVie opens new 23m Dublin facility US pharma group AbbVie has officially opened a new 23m European manufacturing services hub in Dublin Sep 21, 2023 8:44 AM
Seeking Alpha (ABBV,4AB-GF,4AB-GM,4AB-GY,4AB-GS,4AB-GD,4AB-GB,FDA-IM)
Alvotech Humira biosimilar accepted for FDA review Alvotech (ALVO) said Wednesday the U.S. FDA accepted its resubmitted marketing application for a bio Sep 20, 2023 6:56 AM
Finanz Nachrichten (ABBV,4AB-GF,4AB-GM,4AB-GY,4AB-GS,4AB-GD,4AB-GB)
Allergan Aesthetics: Second Phase 3 Study With OnabotulinumtoxinA Meets Endpoints WASHINGTON (dpa-AFX) - Allergan Aesthetics, an AbbVie company (ABBV), reported positive topline resu Sep 18, 2023 9:54 AM
Seeking Alpha (AZN-LN,AZN,ZEGA-GF,ZEGA-GM,ZEGA-GS,ZEGA-GD,ZEGA-GB,AZNCF,AZN-SS,ZEG-GF,ZEG-GM,ZEG-GY,ZEG-GH,ZEG-GS,ZEG-GI,ZEG-GD,ZEG-GB,ABBV,4AB-GF,4AB-GM,4AB-GY,4AB-GS,4AB-GD,4AB-GB)
AbbVie Vs. AstraZeneca: Battle Of The Pharmaceutical Behemoths AstraZeneca''s (AZN) strong revenue growth outperforms AbbVie''s (ABBV) declining sales. Click here Sep 15, 2023 1:02 PM
Insider Monkey (ABBV,4AB-GF,4AB-GM,4AB-GY,4AB-GS,4AB-GD,4AB-GB)
AbbVie (ABBV) Fell in Q2 Due to Competition Diamond Hill Capital, an investment management company, released its “Large Cap Strategy” second-qua Sep 15, 2023 8:32 AM
Seeking Alpha (ABBV,4AB-GF,4AB-GM,4AB-GY,4AB-GS,4AB-GD,4AB-GB,HARP)
Harpoon up even as AbbVie declines license option for cancer asset Harpoon Therapeutics (HARP) is down ~8% in after-hours trading after AbbVie (ABBV) declined to exerc Sep 13, 2023 5:22 PM
FiercePharma (ABBV,4AB-GF,4AB-GM,4AB-GY,4AB-GS,4AB-GD,4AB-GB)
AbbVie''s Skyrizi deals heavy blow to J&J''s Stelara in head-to-head Crohn''s disease study AbbVie''s Skyrizi deals heavy blow to J&J''s Stelara in head-to-head Crohn''s disease study aliu Tue Sep 12, 2023 11:16 AM
Common Questions Related to Abbvie Inc
When is Abbvie Inc next earning date?
Abbvie Inc next earning date is 2023-10-27
What is dividend yield of Abbvie Inc stock?
Abbvie Inc dividend yield is 0.037264905726050686 and Abbvie Inc announced last dividend in 2023-07-13 of amount $5.76/stock.
What is Abbvie Inc stock symbol?
Abbvie Inc traded in NEW YORK STOCK EXCHANGE INC. stock exchange and the stock symbol/ticker is ABBV
What is the latest share price of Abbvie Inc (ABBV)? or What is Abbvie Inc stock price today?
Abbvie Inc latest stock price is $153.91
Where is Abbvie Inc headquarter?
Abbvie Inc headquarter is at – 1 N Waukegan Rd, North Chicago, Illinois, US
What is the total market cap of Abbvie Inc company?
The total market value of Abbvie Inc stock is $ 272.96 B
What is the P/E ratio of Abbvie Inc stock?
Abbvie Inc P/E ratio is 31.58579831775052
What is the EPS of Abbvie Inc stock?
Abbvie Inc EPS is 4.87
What is the Beta of Abbvie Inc stock?
Abbvie Inc Beta is 0.3318666378433722
Related Tags
Abbvie Inc stock price history, Abbvie Inc stock quote, ABBV current stock price, Abbvie Inc dividend yield, Abbvie Inc Dividend, How much is Abbvie Inc worth